BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 5697207)

  • 1. [Remarks on the percutaneous absorption of corticoids].
    Rimbaud P; Meynadier J
    Ann Dermatol Syphiligr (Paris); 1968; 95(3):263-7. PubMed ID: 5697207
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of corticosteroids on human epidermal mitotic activity.
    Fisher LB; Maibach HI
    Arch Dermatol; 1971 Jan; 103(1):39-44. PubMed ID: 4321801
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract]   [Full Text] [Related]  

  • 4. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].
    Weirich EG; Lutz U
    Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215
    [No Abstract]   [Full Text] [Related]  

  • 5. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test.
    Coldman MF; Lockerbie L; Laws EA
    Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacology of dermatocorticoids (2. Continuation)].
    Weirich EG
    Z Hautkr; 1978 Apr; 53(7):209-16 contd. PubMed ID: 645170
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasoconstrictor and systemic activities of topical steroids.
    Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA
    Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of the degree of dispersion and of the type of ointment base on the skin absorption of hydrocortisone and prednisolone ointments].
    Skripkin IuK; Dobrotvorskiĭ AE; Demidova NM; Aliushin MT
    Vestn Dermatol Venerol; 1974 May; 48(5):19-21. PubMed ID: 4839253
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cutaneus vasoconstrictive effect of mineralocorticoids].
    Weirich EG; Lutz U
    Arch Dermatol Forsch; 1974; 250(4):359-68. PubMed ID: 4447377
    [No Abstract]   [Full Text] [Related]  

  • 10. The psoriasis bio-assay for topical corticosteroid activity.
    Dumas KJ; Scholtz JR
    Acta Derm Venereol; 1972; 52(1):43-8. PubMed ID: 4111105
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimization of topical therapy of psoriasis.
    Wohlrab W; Wozniak KD; Taube KM
    Acta Univ Carol Med (Praha); 1986; 32(3-4):249-54. PubMed ID: 3434484
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical corticosteroids.
    Pace WE
    Can Med Assoc J; 1973 Jan; 108(1):ll passim. PubMed ID: 4682644
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of 2d degree burns with Oxycort-aerosol and Synalar ointment under occlusive dressings].
    Lańcucki J; Wysocki C; Ratka P; Ogonowski E
    Przegl Dermatol; 1973; 60(4):537-42. PubMed ID: 4755920
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of the external use of triamcinolone acetonide under foil occlussive dressings on the plasma cortisol level and on the diurnal rhythm of plasma cortisol].
    Hartmann F; Lahmann JJ
    Hautarzt; 1977 Apr; 28(4):198-202. PubMed ID: 559653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial.
    Smith EB; Gregory JF; Bartruff JK
    South Med J; 1973 Mar; 66(3):325-9. PubMed ID: 4570656
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of eczema].
    Harnack K
    Z Arztl Fortbild (Jena); 1974 Jun; 68(11):534-8. PubMed ID: 4439985
    [No Abstract]   [Full Text] [Related]  

  • 17. Gels and other topical corticosteroids.
    Med Lett Drugs Ther; 1974 Jun; 16(12):50-2. PubMed ID: 4831241
    [No Abstract]   [Full Text] [Related]  

  • 18. Objective measurement of topically applied corticosteroids.
    Király K; Soós G
    Dermatologica; 1976; 152 Suppl 1():133-7. PubMed ID: 955233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoconstrictor potency of corticoids: intradermal injection.
    Sutton PM; Feldmann RJ; Maibach HI
    J Invest Dermatol; 1971 Dec; 57(6):371-6. PubMed ID: 5127971
    [No Abstract]   [Full Text] [Related]  

  • 20. The physical, animal and human pharmacologic, and toxicologic properties of desonide, a new, topically active, antiinflammatory steroid.
    Phillips BM; Sanen FJ; Leeling JL; Hammes TL; Hartnagel RE; Sancilio LF; Lorenzetti OJ; Kraus PJ
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):522-37. PubMed ID: 5143593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.